Mannkind logo

Mannkind share price today

(MNKD)

Mannkind share price is $6.85 & ₹582.09 as on 21 Dec 2024, 2.30 'hrs' IST

$6.85

0.55

(8.73%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Mannkind share price in Dollar and Rupees. Guide to invest in Mannkind from India. Also see the sentimental analysis on Indian investors investing in Mannkind. Get details on the Indian mutual funds that are investing in Mannkind. Get Analyst recommendations and forecasts along with all the Mannkind's financials.

Mannkind share price movements

  • Today's Low: $6.42
    Today's High: $7.07

    Day's Volatility :9.13%

  • 52 Weeks Low: $3.17
    52 Weeks High: $7.63

    52 Weeks Volatility :58.45%

Mannkind Returns

PeriodMannkind Corp.Sector (Health Care)Index (Russel 2000)
3 Months
-3.37%
-12.2%
0.0%
6 Months
16.02%
-6.9%
0.0%
1 Year
75.0%
2.7%
0.0%
3 Years
42.86%
-0.2%
-17.3%

Mannkind Key Statistics

in dollars & INR

Previous Close
$6.3
Open
$6.34
Today's High
$7.065
Today's Low
$6.42
Market Capitalization
$1.6B
Today's Volume
$3.5M
52 Week High
$7.63
52 Week Low
$3.17
Revenue TTM
$267.2M
EBITDA
$63.7M
Earnings Per Share (EPS)
$0.08
PE Ratio
74.25
Profit Margin
8.07%
Quarterly Earnings Growth YOY
5.25%
Return On Equity TTM
0.0%

How to invest in Mannkind from India?

It is very easy for Indian residents to invest directly in Mannkind from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Mannkind stock in both Indian Rupees (INR) and US Dollars (USD). Search for Mannkind or MNKD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Mannkind or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Mannkind shares which would translate to 0.124 fractional shares of Mannkind as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Mannkind, in just a few clicks!

Returns in Mannkind for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Mannkind investment value today

Current value as on today

₹1,92,373

Returns

₹92,373

(+92.37%)

Returns from Mannkind Stock

₹90,278 (+90.28%)

Dollar Returns

₹2,095 (+2.1%)

Indian investors sentiment towards Mannkind

-4%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Mannkind on INDmoney from India has reduced in the last 30 days as on Dec 21, 2024. -4% less investors are searching Mannkind in the last 30 days versus the previous period.

Global Institutional Holdings in Mannkind

  • BlackRock Inc

    8.18%

  • Vanguard Group Inc

    5.67%

  • State Street Corp

    3.48%

  • Nitorum Capital, L.P.

    3.32%

  • venBio Select Advisor LLC

    3.17%

  • Geode Capital Management, LLC

    2.30%

Analyst Recommendation on Mannkind

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Mannkind(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Mannkind

What analysts predicted

Upside of 35.04%

Current:

$6.85

Target:

$9.25

Insights on Mannkind

  • Price Movement

    In the last 1 year, MNKD stock has moved up by 88.9%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 72.38M → 70.07M (in $), with an average decrease of 3.2% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -2.01M → 11.55M (in $), with an average increase of 117.4% per quarter

Mannkind Financials in INR & Dollars

FY18Y/Y Change
Revenue
$27.9M
↑ 137.2%
Net Income
$-87.0M
↓ 25.87%
Net Profit Margin
-312.2%
↑ 686.8%
FY19Y/Y Change
Revenue
$63.0M
↑ 126.28%
Net Income
$-59.7M
↓ 31.33%
Net Profit Margin
-94.75%
↑ 217.45%
FY20Y/Y Change
Revenue
$65.1M
↑ 3.34%
Net Income
$-57.2M
↓ 4.17%
Net Profit Margin
-87.87%
↑ 6.88%
FY21Y/Y Change
Revenue
$75.4M
↑ 15.81%
Net Income
$-91.8M
↑ 60.36%
Net Profit Margin
-121.67%
↓ 33.8%
FY22Y/Y Change
Revenue
$99.8M
↑ 32.25%
Net Income
$-112.2M
↑ 22.2%
Net Profit Margin
-112.43%
↑ 9.24%
FY23Y/Y Change
Revenue
$199.0M
↑ 99.42%
Net Income
$-11.9M
↓ 89.36%
Net Profit Margin
-6.0%
↑ 106.43%
Q2 FY23Q/Q Change
Revenue
$48.6M
↑ 19.65%
Net Income
$-5.3M
↓ 67.13%
Net Profit Margin
-10.83%
↑ 28.59%
Q3 FY23Q/Q Change
Revenue
$51.3M
↑ 5.43%
Net Income
$1.7M
↓ 132.69%
Net Profit Margin
3.36%
↑ 14.19%
Q4 FY23Q/Q Change
Revenue
$58.5M
↑ 14.09%
Net Income
$1.4M
↓ 18.59%
Net Profit Margin
2.4%
↓ 0.96%
Q1 FY24Q/Q Change
Revenue
$66.3M
↑ 13.32%
Net Income
$10.6M
↑ 658.74%
Net Profit Margin
16.04%
↑ 13.64%
Q2 FY24Q/Q Change
Revenue
$72.4M
↑ 9.24%
Net Income
$-2.0M
↓ 118.95%
Net Profit Margin
-2.78%
↓ 18.82%
Q3 FY24Q/Q Change
Revenue
$70.1M
↓ 3.19%
Net Income
$11.6M
↓ 673.49%
Net Profit Margin
16.48%
↑ 19.26%
FY18Y/Y Change
Profit
$7.4M
↓ 234.6%
FY19Y/Y Change
Profit
$35.1M
↑ 375.05%
FY20Y/Y Change
Profit
$40.5M
↑ 15.53%
FY21Y/Y Change
Profit
$36.6M
↓ 9.67%
FY22Y/Y Change
Profit
$42.3M
↑ 15.55%
FY23Y/Y Change
Profit
$136.2M
↑ 222.17%
Q2 FY23Q/Q Change
Profit
$34.4M
↑ 40.8%
Q3 FY23Q/Q Change
Profit
$37.0M
↑ 7.64%
Q4 FY23Q/Q Change
Profit
$40.4M
↑ 9.21%
Q1 FY24Q/Q Change
Profit
$47.7M
↑ 17.97%
Q2 FY24Q/Q Change
Profit
$52.0M
↑ 9.11%
Q3 FY24Q/Q Change
Profit
$52.1M
↑ 0.09%
FY18Y/Y Change
Operating Cash Flow
$-37.7M
↓ 41.75%
Investing Cash Flow
$-234.0K
↓ 101.4%
Financing Cash Flow
$61.3M
↓ 16.68%
FY19Y/Y Change
Operating Cash Flow
$-88.5M
↑ 134.51%
Investing Cash Flow
$-22.8M
↑ 9661.97%
Financing Cash Flow
$69.9M
↑ 13.98%
FY20Y/Y Change
Operating Cash Flow
$-28.1M
↓ 68.21%
Investing Cash Flow
$15.2M
↓ 166.61%
Financing Cash Flow
$49.9M
↓ 28.64%
FY21Y/Y Change
Operating Cash Flow
$-61.7M
↑ 119.39%
Investing Cash Flow
$-151.5M
↓ 1095.91%
Financing Cash Flow
$270.3M
↑ 442.13%
FY22Y/Y Change
Operating Cash Flow
$-80.7M
↑ 30.74%
Investing Cash Flow
$4.9M
↓ 103.22%
Financing Cash Flow
$21.4M
↓ 92.08%
Q2 FY23Q/Q Change
Operating Cash Flow
$2.6M
↑ 124.57%
Investing Cash Flow
$3.7M
↓ 73.43%
Financing Cash Flow
$-5.9M
↓ 581.4%

Mannkind Technicals Summary

Sell

Neutral

Buy

Mannkind is currently in a neutral trading position according to technical analysis indicators.

Mannkind Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Mannkind Corp.
-8.43%
16.02%
75.0%
42.86%
380.92%
Regeneron Pharmaceuticals, Inc.
-4.72%
-33.43%
-16.35%
14.7%
89.27%
Biontech Se
9.01%
28.55%
5.71%
-57.13%
220.59%
Alnylam Pharmaceuticals, Inc.
-3.99%
7.16%
25.05%
27.48%
103.59%
Vertex Pharmaceuticals Incorporated
-12.1%
-16.49%
-2.12%
78.05%
80.31%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Mannkind Corp.
74.25
74.25
-0.23
0.11
0.0
0.09
NA
-0.76
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.05
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Mannkind Corp.
Buy
$1.6B
380.92%
74.25
8.07%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
89.27%
17.67
33.61%
Biontech Se
Buy
$26.8B
220.59%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.7B
103.59%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$115.2B
80.31%
32.84
-4.51%

About Mannkind

mannkind corporation (nasdaq: mnkd) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. in addition, mannkind is applying our novel technologies and services to support partner development efforts.
Organization
Mannkind
Employees
411
CEO
Dr. Michael E. Castagna Pharm.D.
Industry
Health Technology

Management People of Mannkind

NameTitle
Dr. Michael E. Castagna Pharm.D.
CEO & Director
Ms. Lauren M. Sabella
Chief Operating Officer
Dr. David B. Thomson J.D., Ph.D.
Executive VP, General Counsel & Secretary
Dr. Stuart A. Tross Ph.D.
Executive VP and Chief People & Workplace Officer
Mr. Christopher B. Prentiss M.B.A.
Chief Financial Officer
Mr. Sanjay Singh M.B.A.
Executive Vice President of Technical Operations
Ms. Rosabel Realica Alinaya CPA
VP of Investor Relations & Treasury
Mr. John F. Bedard
Senior Vice President of Worldwide Regulatory Affairs
Mr. James Patrick McCauley Jr., J.D., M.B.A.
Chief Commercial Officer
Dr. Burkhard Blank M.D.
Executive VP of Research & Development and Chief Medical Officer

Important FAQs about investing in Mannkind from India :

What is Mannkind share price today?

Mannkind share price today stands at $6.85, Open: $6.34 ; Previous Close: $6.30 ; High: $7.07 ; Low: $6.42 ; 52 Week High: $7.63 ; 52 Week Low: $3.17. The stock opens at $6.34, after a previous close of $6.30. The stock reached a daily high of $7.07 and a low of $6.42, with a 52-week high of $7.63 and a 52-week low of $3.17.

Can Indians buy Mannkind shares?

Yes, Indians can invest in the Mannkind (MNKD) from India.

With INDmoney, you can buy Mannkind at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Mannkind at zero transaction cost.

How can I buy Mannkind shares from India?

It is very easy to buy Mannkind from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Mannkind be purchased?

Yes, you can buy fractional shares of Mannkind with INDmoney app.

What are the documents required to start investing in Mannkind stocks?

To start investing in Mannkind, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Mannkind

Today’s highest price of Mannkind (MNKD) is $7.07.

Today’s lowest price of Mannkind (MNKD) is $6.42.

What is today's market capitalisation of Mannkind

Today's market capitalisation of Mannkind MNKD is 1.6B

What is the 52 Week High and Low Range of Mannkind

  • 52 Week High

    $7.63

  • 52 Week Low

    $3.17

What are the historical returns of Mannkind?

  • 1 Month Returns

    -8.43%

  • 3 Months Returns

    16.02%

  • 1 Year Returns

    75%

  • 5 Years Returns

    380.92%

Who is the Chief Executive Officer (CEO) of Mannkind

Dr. Michael E. Castagna Pharm.D. is the current Chief Executive Officer (CEO) of Mannkind.